Hormone Treatment did not Improve Survival in Men With Prostate Cancer, Study

July 15, 2014 4:09 AM

25 0

Worldwide, prostate cancer is the second most common cancer. If the disease spreads beyond the prostate, a small gland found close to the bladder, then it becomes far more difficult to treat. Patients with early prostate cancer are given androgen deprivation treatment, or ADT, as a first line of treatment. These stop the body from making too much testosterone, which fuels prostate cancer.

According to a large new analysis, published in the journal JAMA Internal Medicine, a team led by Dr. Grace Lu-Yao, a professor of medicine at the Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School in New Brunswick, N.J., found that so-called androgen deprivation therapy d...

Read more

To category page